None listed
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Adults aged between 19 and 80 years old. (2)Individuals diagnosed with early-stage gastric cancer, where the lesion is well-differentiated and not deeply invasive, indicating no likelihood of regional lymph node metastasis. (3)Individuals who meet the indications for ESD. (4)Individuals for whom, in the opinion of the principal investigator, clinical efficacy through ESD is unlikely. (5)Individuals who have received a detailed explanation of this clinical trial, fully understood it, and voluntarily agreed to participate by signing a written consent form.
Exclusion criteria
Exclusion criteria: (1)Individuals with a pacemaker due to heart disease. (2)Individuals with any other implanted electronic devices. (3)Individuals with colon obstruction and bleeding. (4)Individuals with GFR (glomerular filtration rate) less than 30. (5)Individuals with inflammatory bowel disease or pregnant women. (6)Individuals who have undergone gastrointestinal resection or abdominal surgery. (7)Individuals who refuse to provide informed consent. (8)Individuals with a history of hypersensitivity reactions to substances used in previous studies or those containing soy or egg components. (9)Individuals with a systolic blood pressure below 80 mmHg or an oxygen saturation level below 90%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Procedure time (total time, dissection time), time required for each lesion location, time required for traction tasks, dissection speed (area/dissection time) | — |
Secondary
| Measure | Time frame |
|---|---|
| En bloc resection, complete resection, and bleeding status. | — |
Countries
Korea, Republic of
Contacts
Korea University Anam Hospital